MedTrace Logo

Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections

NCT03189043 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10000

Last updated 2017-06-16

No results posted yet for this study

Summary

This is a controlled open label efficacy study of Aionx antimicrobial surface for the prevention of healthcare-associated infections.

Conditions

  • Healthcare Associated Infection

Interventions

DEVICE

Antimicrobial Surface

Antimicrobial Surface

Sponsors & Collaborators

  • Aionx, Inc.

    lead INDUSTRY

Principal Investigators

  • Jose A Stoute, M.D. · Milton S. Hershey Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2017-10-01
Completion
2017-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189043 on ClinicalTrials.gov